Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2574235013 | Acetaminophen 325mg/propoxyphene napsylate 100mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2577575011 | Acetaminophen 325mg/propoxyphene napsylate 100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2577576012 | Paracetamol 325mg/propoxyphene napsylate 100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3469789017 | Product containing acetaminophen 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469790014 | Product containing paracetamol 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3487101014 | Product containing paracetamol 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3502075017 | Acetaminophen 325 mg and propoxyphene napsylate 100 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3502076016 | Paracetamol 325 mg and propoxyphene napsylate 100 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570295019 | Product containing only acetaminophen 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570296018 | Product containing only paracetamol 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570297010 | Product containing only paracetamol 325 mg and propoxyphene napsylate 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681582012 | Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3681583019 | Dextropropoxyphene napsylate 100 mg and paracetamol 325 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681584013 | Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 105052801000001113 | Paracetamol 325mg/propoxyphene napsylate 100mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol and propoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has precise active ingredient | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing dextropropoxyphene and paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets